Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Sep 26, 2013
Insider Transaction Report
Form 4
Seaman Scott B
Director
Transactions
- Conversion
Common Stock
2013-09-24$1.91/sh+269,182$514,138→ 518,708 total(indirect: See footnote.) - Conversion
Convertible Promissory Note
2013-09-24→ 0 total(indirect: See footnote.)Exercise: $1.91From: 2012-07-25Exp: 2014-07-25→ Common Stock (269,182 underlying)
Holdings
- 10,913
Common Stock
Footnotes (2)
- [F1]Held by Alkek & Williams Ventures, Ltd. ("Ventures"). Chaswil, Ltd. ("Chaswil") is the investment manager of Ventures and holds voting power and investment power with respect to the Issuer securities held by Ventures. Mr. Seaman is a registered principal of Chaswil and has shared voting power and/or investment power with respect to the Issuer securities held by Ventures. Mr. Seaman disclaims beneficial ownership of the shares held by Ventures except to the extent of any pecuniary interest therein.
- [F2]On September 23, 2013, the Note was amended to provide that in addition to the existing conversion arrangements (i.e., convertible at the election of the Holder or the Issuer into Convertible Preferred Stock at a conversion price of $100), the Note also became convertible at the Issuer's election directly into Common Stock (rather than any intermediate conversion to Convertible Preferred Stock) at the most recent closing market price (subject to a market price range) of the Common Stock at the time of any election by the Issuer to convert the Note directly into Common Stock. On September 24, 2013, the Issuer converted the principal balance of the Note plus accrued interest into 269,182 shares of Common Stock at a conversion price of $1.91.